Celltrion

Four domestic corona treatments will be released in the first quarter

[금일 제약업계 주요기사]Celltrion, Corona 19 Antibody Treatment Phase 2 Results… Seegene, global business expansion’Start’, etc.

‘Giant’ Seo Jeong-jin, Chairman of Celltrion, left three major footsteps

Celltrion unveils results of phase 2 clinical trials for corona antibody treatment

Celltrion released the results of global clinical trials for COVID-19 treatment on the 13th

Celltrion Antibody Therapy Phase 2 Clinical Results Coming Out on the 13th

Celltrion reveals the results of phase 2 clinical trials of’corona antibody treatment’ on the 13th

Celltrion announced the results of phase 2 clinical trials for Rekirona on the 13th

Celltrion unveils the results of phase 2 clinical trials for corona antibody treatment for the first time on the 13th

Jeong-Jin Seo Special order for completion of development in 2020… Celltrion Researcher’s Life

65-year-old Seo Jung-jin, who left Celltrion, sets up a blood test startup

Celltrion “Incheon Songdo Biocluster Construction Project”